Improved Detection of Invasive Pulmonary Aspergillosis Arising during Leukemia Treatment Using a Panel of Host Response Proteins and Fungal Antigens.
Invasive pulmonary aspergillosis (IPA) is an opportunistic fungal infection in patients undergoing chemotherapy for hematological malignancy, hematopoietic stem cell transplant, or other forms of immunosuppression. In this group, Aspergillus infections account for the majority of deaths due to mold...
Main Authors: | , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4651335?pdf=render |
id |
doaj-dd386721def0487ca837feeb95899efa |
---|---|
record_format |
Article |
spelling |
doaj-dd386721def0487ca837feeb95899efa2020-11-25T01:18:47ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-011011e014316510.1371/journal.pone.0143165Improved Detection of Invasive Pulmonary Aspergillosis Arising during Leukemia Treatment Using a Panel of Host Response Proteins and Fungal Antigens.Allan R BrasierYingxin ZhaoHeidi M SprattJohn E WiktorowiczHyunsu JuL Joseph WheatLindsey BadenSusan StaffordZheng WuNicolas IssaAngela M CaliendoDavid W DenningKizhake SomanCornelius J ClancyM Hong NguyenMichele W SugrueBarbara D AlexanderJohn R WingardInvasive pulmonary aspergillosis (IPA) is an opportunistic fungal infection in patients undergoing chemotherapy for hematological malignancy, hematopoietic stem cell transplant, or other forms of immunosuppression. In this group, Aspergillus infections account for the majority of deaths due to mold pathogens. Although early detection is associated with improved outcomes, current diagnostic regimens lack sensitivity and specificity. Patients undergoing chemotherapy, stem cell transplantation and lung transplantation were enrolled in a multi-site prospective observational trial. Proven and probable IPA cases and matched controls were subjected to discovery proteomics analyses using a biofluid analysis platform, fractionating plasma into reproducible protein and peptide pools. From 556 spots identified by 2D gel electrophoresis, 66 differentially expressed post-translationally modified plasma proteins were identified in the leukemic subgroup only. This protein group was rich in complement components, acute-phase reactants and coagulation factors. Low molecular weight peptides corresponding to abundant plasma proteins were identified. A candidate marker panel of host response (9 plasma proteins, 4 peptides), fungal polysaccharides (galactomannan), and cell wall components (β-D glucan) were selected by statistical filtering for patients with leukemia as a primary underlying diagnosis. Quantitative measurements were developed to qualify the differential expression of the candidate host response proteins using selective reaction monitoring mass spectrometry assays, and then applied to a separate cohort of 57 patients with leukemia. In this verification cohort, a machine learning ensemble-based algorithm, generalized pathseeker (GPS) produced a greater case classification accuracy than galactomannan (GM) or host proteins alone. In conclusion, Integration of host response proteins with GM improves the diagnostic detection of probable IPA in patients undergoing treatment for hematologic malignancy. Upon further validation, early detection of probable IPA in leukemia treatment will provide opportunities for earlier interventions and interventional clinical trials.http://europepmc.org/articles/PMC4651335?pdf=render |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Allan R Brasier Yingxin Zhao Heidi M Spratt John E Wiktorowicz Hyunsu Ju L Joseph Wheat Lindsey Baden Susan Stafford Zheng Wu Nicolas Issa Angela M Caliendo David W Denning Kizhake Soman Cornelius J Clancy M Hong Nguyen Michele W Sugrue Barbara D Alexander John R Wingard |
spellingShingle |
Allan R Brasier Yingxin Zhao Heidi M Spratt John E Wiktorowicz Hyunsu Ju L Joseph Wheat Lindsey Baden Susan Stafford Zheng Wu Nicolas Issa Angela M Caliendo David W Denning Kizhake Soman Cornelius J Clancy M Hong Nguyen Michele W Sugrue Barbara D Alexander John R Wingard Improved Detection of Invasive Pulmonary Aspergillosis Arising during Leukemia Treatment Using a Panel of Host Response Proteins and Fungal Antigens. PLoS ONE |
author_facet |
Allan R Brasier Yingxin Zhao Heidi M Spratt John E Wiktorowicz Hyunsu Ju L Joseph Wheat Lindsey Baden Susan Stafford Zheng Wu Nicolas Issa Angela M Caliendo David W Denning Kizhake Soman Cornelius J Clancy M Hong Nguyen Michele W Sugrue Barbara D Alexander John R Wingard |
author_sort |
Allan R Brasier |
title |
Improved Detection of Invasive Pulmonary Aspergillosis Arising during Leukemia Treatment Using a Panel of Host Response Proteins and Fungal Antigens. |
title_short |
Improved Detection of Invasive Pulmonary Aspergillosis Arising during Leukemia Treatment Using a Panel of Host Response Proteins and Fungal Antigens. |
title_full |
Improved Detection of Invasive Pulmonary Aspergillosis Arising during Leukemia Treatment Using a Panel of Host Response Proteins and Fungal Antigens. |
title_fullStr |
Improved Detection of Invasive Pulmonary Aspergillosis Arising during Leukemia Treatment Using a Panel of Host Response Proteins and Fungal Antigens. |
title_full_unstemmed |
Improved Detection of Invasive Pulmonary Aspergillosis Arising during Leukemia Treatment Using a Panel of Host Response Proteins and Fungal Antigens. |
title_sort |
improved detection of invasive pulmonary aspergillosis arising during leukemia treatment using a panel of host response proteins and fungal antigens. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2015-01-01 |
description |
Invasive pulmonary aspergillosis (IPA) is an opportunistic fungal infection in patients undergoing chemotherapy for hematological malignancy, hematopoietic stem cell transplant, or other forms of immunosuppression. In this group, Aspergillus infections account for the majority of deaths due to mold pathogens. Although early detection is associated with improved outcomes, current diagnostic regimens lack sensitivity and specificity. Patients undergoing chemotherapy, stem cell transplantation and lung transplantation were enrolled in a multi-site prospective observational trial. Proven and probable IPA cases and matched controls were subjected to discovery proteomics analyses using a biofluid analysis platform, fractionating plasma into reproducible protein and peptide pools. From 556 spots identified by 2D gel electrophoresis, 66 differentially expressed post-translationally modified plasma proteins were identified in the leukemic subgroup only. This protein group was rich in complement components, acute-phase reactants and coagulation factors. Low molecular weight peptides corresponding to abundant plasma proteins were identified. A candidate marker panel of host response (9 plasma proteins, 4 peptides), fungal polysaccharides (galactomannan), and cell wall components (β-D glucan) were selected by statistical filtering for patients with leukemia as a primary underlying diagnosis. Quantitative measurements were developed to qualify the differential expression of the candidate host response proteins using selective reaction monitoring mass spectrometry assays, and then applied to a separate cohort of 57 patients with leukemia. In this verification cohort, a machine learning ensemble-based algorithm, generalized pathseeker (GPS) produced a greater case classification accuracy than galactomannan (GM) or host proteins alone. In conclusion, Integration of host response proteins with GM improves the diagnostic detection of probable IPA in patients undergoing treatment for hematologic malignancy. Upon further validation, early detection of probable IPA in leukemia treatment will provide opportunities for earlier interventions and interventional clinical trials. |
url |
http://europepmc.org/articles/PMC4651335?pdf=render |
work_keys_str_mv |
AT allanrbrasier improveddetectionofinvasivepulmonaryaspergillosisarisingduringleukemiatreatmentusingapanelofhostresponseproteinsandfungalantigens AT yingxinzhao improveddetectionofinvasivepulmonaryaspergillosisarisingduringleukemiatreatmentusingapanelofhostresponseproteinsandfungalantigens AT heidimspratt improveddetectionofinvasivepulmonaryaspergillosisarisingduringleukemiatreatmentusingapanelofhostresponseproteinsandfungalantigens AT johnewiktorowicz improveddetectionofinvasivepulmonaryaspergillosisarisingduringleukemiatreatmentusingapanelofhostresponseproteinsandfungalantigens AT hyunsuju improveddetectionofinvasivepulmonaryaspergillosisarisingduringleukemiatreatmentusingapanelofhostresponseproteinsandfungalantigens AT ljosephwheat improveddetectionofinvasivepulmonaryaspergillosisarisingduringleukemiatreatmentusingapanelofhostresponseproteinsandfungalantigens AT lindseybaden improveddetectionofinvasivepulmonaryaspergillosisarisingduringleukemiatreatmentusingapanelofhostresponseproteinsandfungalantigens AT susanstafford improveddetectionofinvasivepulmonaryaspergillosisarisingduringleukemiatreatmentusingapanelofhostresponseproteinsandfungalantigens AT zhengwu improveddetectionofinvasivepulmonaryaspergillosisarisingduringleukemiatreatmentusingapanelofhostresponseproteinsandfungalantigens AT nicolasissa improveddetectionofinvasivepulmonaryaspergillosisarisingduringleukemiatreatmentusingapanelofhostresponseproteinsandfungalantigens AT angelamcaliendo improveddetectionofinvasivepulmonaryaspergillosisarisingduringleukemiatreatmentusingapanelofhostresponseproteinsandfungalantigens AT davidwdenning improveddetectionofinvasivepulmonaryaspergillosisarisingduringleukemiatreatmentusingapanelofhostresponseproteinsandfungalantigens AT kizhakesoman improveddetectionofinvasivepulmonaryaspergillosisarisingduringleukemiatreatmentusingapanelofhostresponseproteinsandfungalantigens AT corneliusjclancy improveddetectionofinvasivepulmonaryaspergillosisarisingduringleukemiatreatmentusingapanelofhostresponseproteinsandfungalantigens AT mhongnguyen improveddetectionofinvasivepulmonaryaspergillosisarisingduringleukemiatreatmentusingapanelofhostresponseproteinsandfungalantigens AT michelewsugrue improveddetectionofinvasivepulmonaryaspergillosisarisingduringleukemiatreatmentusingapanelofhostresponseproteinsandfungalantigens AT barbaradalexander improveddetectionofinvasivepulmonaryaspergillosisarisingduringleukemiatreatmentusingapanelofhostresponseproteinsandfungalantigens AT johnrwingard improveddetectionofinvasivepulmonaryaspergillosisarisingduringleukemiatreatmentusingapanelofhostresponseproteinsandfungalantigens |
_version_ |
1725140395135860736 |